The Doherty Lab studies the molecular and genomic pathoepidemiology of ovarian and lung cancers to impact prevention, early detection, and survival of these cancer types.
Intermountain Precision Genomics, a program within Intermountain Healthcare, has awarded more than $400,000 in total to researchers at Stanford University, Huntsman Cancer Institute, the University of Utah School of Medicine, and Vivid Genomics to improve individual health.... Read More
Select...Dr. Mollie Barnard’s paper on analgesic use and ovarian cancer risk was selected for the NCI Epidemiology and Genomics Research Program 2018 Research Highlights.... Read More
Select...The latest edition of Utah Cancer Registry's biennial report Cancer in Utah is now available.... Read More
Select...We are pleased to announce that Dr. Jennifer Doherty has been elected MEG Chairperson-elect 2019-2020. Dr. Doherty will assume the office of Chairperson elect at the AACR Annual Meeting 2019, taking place from March 29-April 3, 2019, in Atlanta, GA.... Read More
Select...Congratulations to Jennifer A. Doherty, PhD, MEG Chairperson-elect 2019-2020 Our thanks to Jennifer A. Doherty, PhD, and Leah E. Mechanic, PhD, for standing for election, and to the MEG membership for participating in the election. We congratulate Dr. Doherty on her election as MEG chairperson-elect. Dr. Doherty will assume the office of chairperson-elect at the AACR Annual Meeting 2019, March 29-April 3, in Atlanta, Georgia.... Read More
Select...Huntsman Cancer Institute and the University of Utah will receive up to $28 million over the next 10 years from the National Cancer Institute to continue its participation in the Surveillance Epidemiology and End Results program – or SEER.... Read More
Select...
